Group 1 - The announcement states that from February 9, 2026, China Galaxy Securities will begin selling certain funds managed by the company [1] - The announcement also mentions that Huatai Securities will start selling some of the company's funds from the same date [2] - Investors can consult details through the respective websites and customer service numbers of China Galaxy Securities and the company [1][2] Group 2 - The sales agreements with both securities firms are subject to compliance with fund contracts, prospectuses, and related business announcements [1][2] - Specific details regarding the sales process, types of business, and any fee discount activities will be determined by the sales institutions [1][2]

Core Viewpoint - The announcement details the signing of sales agreements between Shangyin Fund Management Co., Ltd. and multiple fund sales agencies, indicating that these agencies will begin selling certain funds managed by the company starting from February 2, 2026 [1]. Group 1: Fund Sales Agreements - Shangyin Fund Management has entered into sales agreements with various fund sales agencies, including Ant (Hangzhou) Fund Sales Co., Ltd., JD Kenterui Fund Sales Co., Ltd., and others [1]. - The sales will commence on February 2, 2026, involving a range of funds managed by Shangyin Fund [1]. Group 2: Fund Sales Agencies - A total of 44 fund sales agencies are listed, including major players such as Shanghai Tian Tian Fund Sales Co., Ltd., and China International Capital Corporation Wealth Securities Co., Ltd. [1][2][3][4][5][6][7]. - Each agency has provided contact details, including websites and customer service phone numbers, for investors seeking more information [2][3][4][5][6][7].

Fund Overview - The fund is named "Shangyin Medical Selected Stock Fund" and is a type of stock investment fund [14] - The fund is managed by Shangyin Fund Management Co., Ltd. and the custodian is Changsha Bank Co., Ltd. [2][51][52] - The fund will be available for subscription from February 2, 2026, to March 2, 2026 [1][17] Subscription Details - The minimum subscription amount for the fund is set at 1,000,000 RMB for the initiators, while individual investors can start with as little as 1 RMB [6][27] - The fund is open to various types of investors, including individual investors, institutional investors, qualified foreign investors, and others permitted by regulations [5][14] - The fund does not impose a cap on the total amount raised during the subscription period, but the management may adjust the fundraising limits as necessary [5][18] Fund Structure - The fund operates as a contract-based, open-end fund with no fixed duration [14] - Investors can make multiple subscriptions during the fundraising period, but once accepted, subscription applications cannot be revoked [28][29] - The fund will issue two classes of shares: Class A and Class C, with different fee structures [14][22] Investment Strategy - The fund aims to achieve long-term stable appreciation of assets while strictly controlling risks [15] - The fund may invest in various asset classes, including stocks, stock index futures, and asset-backed securities, among others [9][10][11] Management and Custody - The fund management company was established on August 30, 2013, and is wholly owned by Shanghai Bank [51] - The custodian bank, Changsha Bank, has been operational since August 18, 1997, and is responsible for safeguarding the fund's assets [52] Regulatory Compliance - The fund has been registered with the China Securities Regulatory Commission (CSRC) and is subject to its regulations [1] - The fund's contract will become effective upon meeting the legal conditions and after verification by a statutory auditing firm [49]